
5th Int. CeBiTec Research Conference
Drug Conjugates for Directed Therapy
The Center for Biotechnology (CeBiTec) of Bielefeld University cordially invites you to attend the 5th International CeBiTec Research Conference on "Drug Conjugates in Directed Therapy”.
CeBiTec Research Conferences are annual events with thematic focus on a challenging topic in the life sciences. The 2015 conference "Drug Conjugates for Directed Therapy" is being organized by the Marie Skłodowska-Curie European Training Network (ETN) MAGICBULLET, which is currently being funded by the EU in the Horizon 2020 Framework Programme for Research and Innovation.
The scope of the CeBiTec Research Conference will include:
• Antibody-Drug Conjugates
• Peptide-Drug Conjugates
• Targets and Specificity
• New Drugs
• Linker Technologies
• Applications
• Process Development
The conference will be held at the Center for Interdisciplinary Research (ZiF) of Bielefeld University from September 20th to 23rd, 2015.
Conference Schedule
Conference Flyer
Confirmed speakers
Jan Anderl | Heidelberg Pharma, DE |
Antibody-Drug Conjugates Based on RNA Polymerase II Inhibiting Payloads
|
|
James Baker | University College London, UK |
The Next Generation Maleimide platform for the construction of homogeneous protein conjugates
|
|
Annette Beck-Sickinger | Leipzig University, DE |
Targeted cancer diagnosis and therapy with peptide conjugates
|
|
Ravi J. Chari | ImmunoGen, Waltham, US |
Antibody-Drug Conjugates: Pathway from a concept to the clinic
|
|
Donald M. Engelman | Yale University, US |
pHLIP® targeting and delivery of PNA in vivo to silence microRNA in acidic tumor cells
|
|
Cesare Gennari | Universitá degli Studi di Milano, IT |
Tumor targeting via integrin ligands: Synthesis and biological evaluation of RGD peptidomimetic-Paclitaxel conjugates
|
|
Ulf Grawunder | NBE Therapeutics, CH |
SMAC-Technology – generation of site-specifically conjugated ADCs by highly efficient enzymatic conjugation
|
|
Nicolas Joubert | Université de Tours, FR |
A new chemical platform for the modular construction of homogeneous Antibody-Drug Conjugates
|
|
Horst Kessler | TU München, DE |
Selective addressing integrin subtypes for drug research, molecular imaging and biophysical studies
|
|
Felix Kratz | CytRx Corporation, DE |
Albumin-based drug delivery systems in oncology: From bench to bedside
|
|
Pirjo Laakkonen | Biomedicum Helsinki, FI |
Peptide-based tumor targeting
|
|
Maxime Lampilas | Sanofi, Vitry sur Seine, FR |
Process development of SPDB/DM4 conjugates
|
|
Hans-Georg Lerchen | Bayer, DE |
Targeted drug conjugates: Challenges in the interface between small molecules and proteins
|
|
Marilena Manea | University of Konstanz, DE |
Drug delivery systems containing GnRH-III peptide as a targeting moiety
|
|
Gábor Mező | MTA-ELTE, HU |
Dual targeting with cyclic NGR peptides
|
|
Ines Neundorf | University of Cologne, DE |
Design and application of cell-penetrating peptides as drug delivery vehicles
|
|
Umberto Piarulli | Università degli Studi dell'Insubria, IT |
Synthesis and biological evaluation of integrin and dual integrin-VEGFR ligands for tumor targeting therapy
|
|
Doron Shabat | Tel Aviv University, IL |
Distinct Developments in Linker Technologies for Bioconjugation
|
|
Fred Valeriote | Henry Ford Health System, Detroit, US |
Discovery of anticancer leads as potential drug conjugates
|
You also may actively participate in the symposium by presenting your work in oral presentations (nearly ten time slots for 20 min oral communications are available) and poster presentations.
We look forward to your contribution!
Registration
Please register to the conference by using the ONLINE REGISTRATION.
Participation will be limited to 140 persons. The registration will be open till August 31st, 2015.
Submission of Abstracts
Please submit your poster or short oral presentation abstract by using the online registration above.
Please apply for
Oral presentation: abstract submission by June 1st, 2015
Poster presentation: abstract submission by August 24th, 2015
Only .doc/.docx or .rtf files can be submitted.
For abstracts, please use the template provided HERE
Registration fee
Attendee's affiliation/status:
Until August 21st, 2015 |
After August 21st, 2015 |
||
Junior Scientist |
€ 150 |
Junior Scientist | € 200 |
Senior Scientist |
€ 300 |
Senior Scientist | € 350 |
Industry Attendee |
€ 500 |
Industry Attendee | € 600 |
(Junior scientist applies to: Students, PhD students, Postdoctoral research fellows max. two years after PhD graduation).
The registration fee covers the conference materials including book of abstracts, snacks, coffee and lunch as well as the conference dinner.
Please follow the payment details provided by the ONLINE REGISTRATION process.
Accommodation
You are encouraged to book your accommodation in the Park Inn conference hotel, which provide special rates for conference participants (available until August 21st, 2015).
Single bedroom (including breakfast): Euro 79,-
Double bedroom upon request
Please make your reservations mentioning group reference 24421 at
Park Inn by Radisson Bielefeld
Telephone: +49 521 9238-0
Fax: +49 521 9238-250
Email:
Conference venue
The conference will be held at the Center for Interdisciplinary Research (ZiF) of Bielefeld University, Methoden 1, 33615 Bielefeld.
Travel Information
Detailed information on how to travel to Bielefeld and the Center for Interdisciplinary Research of Bielefeld University can be found HERE.
Further Information
For further information please contact
MAGICBULLET consortium and scientific committee of the 5th International CeBiTec Research Conference:
Cesare Gennari | Universitá degli Studi di Milano, IT |
Pirjo Laakkonen | University of Helsinki, FI |
Gábor Mező | Eőtvős Loránd University Budapest, HU |
Ines Neundorf | University of Cologne, DE |
Andreas Pahl | Heidelberg Pharma GmbH, Ladenburg, DE |
Jan Anderl | Heidelberg Pharma GmbH, Ladenburg, DE |
Umberto Piarulli | Universitá degli Studi dell’ Insubria, IT |
Norbert Sewald | Bielefeld University (Co-ordinator), DE |
Christian Steinkühler | Exiris, Rome, IT |
József Tóvári | National Institute of Oncology, Budapest, HU |
Acknowledgement
The 5th International Bielefeld-CeBiTec Research Conference is jointly organised by the ETN MAGICBULLET, CeBiTec, Bielefeld University and the GFT e.V. (Gesellschaft zur Foerderung des Forschungs- und Technologietransfers in der Universitaet Bielefeld e.V.).
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 642004.
|
|
|
|
![]() |
|